Jeffrey S. Mathiesen - 25 May 2021 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Issuer symbol
PBLA
Transactions as of
25 May 2021
Net transactions value
$0
Form type
4
Filing time
27 May 2021, 20:51:08 UTC
Next filing
04 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBLA Common Stock Award $0 +4,316 +73% $0.000000 10,191 25 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Stock Option (right to buy) Award $0 +12,368 $0.000000 12,368 25 May 2021 Common Stock 12,368 $4.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Scheduled to vest and become exercisable in four equal increments on August 25, 2021, November 24, 2021, February 25, 2022 and the earlier of May 31, 2022 and the day before the company's annual meeting of stockholders to be held in 2022.